...
首页> 外文期刊>Urology >Natural history of PSA increase with and without prostate cancer.
【24h】

Natural history of PSA increase with and without prostate cancer.

机译:在有或没有前列腺癌的情况下,PSA的自然病史都会增加。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To investigate the natural history of prostate-specific antigen (PSA) increase in men with and without prostate cancer to clarify the probability of cancer-related PSA increase. METHODS: Between 1986 and 2001, 504 men aged 79 years or younger with baseline PSA levels of 4.0 ng/mL or less and a PSA increase greater than 4.0 ng/mL on consecutive screening were enrolled in this study. The types of PSA increase were classified as "non-cancer-related PSA increase," "suspicious cancer-related PSA increase," and "cancer-related PSA increase." The probability of a "cancer-related PSA increase" was investigated and stratified by baseline PSA levels and elapsed years until the PSA level increased to greater than 4.0 ng/mL. RESULTS: The probability of a "non-cancer-related increase," "suspicious cancer-related PSA increase," and "cancer-related PSA increase" was 57%, 15%, and 28%, respectively. The PSA velocity before the PSA increase was not significantly different between those with and without prostate cancer. A "non-cancer-related PSA increase" was observed in 92% of those with a PSA increase within 2 years of baseline PSA ranges of 2.0 ng/mL or less. Regardless of elapsed years until a PSA increase to greater than 4.0 ng/mL, a "suspicious cancer-related PSA increase" or "cancer-related PSA increase" was observed in almost one half of those with baseline PSA levels of 2.1 to 4.0 ng/mL. CONCLUSIONS: Intensive serial observations should be recommended before undergoing biopsy for those with a PSA increase within 2 years of a baseline PSA range of 0.0 to 2.0 ng/mL. It may be difficult to distinguish between those with and without cancer using only subsequent total PSA measurements for the remaining cases, and prostate biopsy should be recommended at present.
机译:目的:调查患有或不患有前列腺癌的男性前列腺特异性抗原(PSA)升高的自然史,以阐明与癌症相关的PSA升高的可能性。方法:在1986年至2001年之间,本研究纳入了504名79岁以下的男性,他们的基线PSA水平为4.0 ng / mL或更低,并且PSA在连续筛查中的增加大于4.0 ng / mL。 PSA增加的类型分为“非癌症相关PSA增加”,“可疑癌症相关PSA增加”和“癌症相关PSA增加”。调查了“癌症相关PSA升高”的可能性,并按基线PSA水平和经过的年数进行了分层,直到PSA水平升高至大于4.0 ng / mL。结果:“非癌相关性增加”,“可疑癌相关性PSA增加”和“癌相关PSA增加”的可能性分别为57%,15%和28%。 PSA增加之前的PSA速度在有和没有前列腺癌的患者之间没有显着差异。在基线PSA范围小于或等于2.0 ng / mL的2年内,PSA增加的患者中有92%观察到“非癌症相关的PSA增加”。不管PSA升高到大于4.0 ng / mL的过去时间,在基线PSA水平为2.1到4.0 ng的患者中,几乎有一半观察到“可疑的癌症相关PSA升高”或“癌症相关的PSA升高”。 /毫升结论:对于基线PSA范围为0.0至2.0 ng / mL的PSA在2年内升高的患者,在进行活检之前应建议进行密集的连续观察。对于其余病例,仅通过后续的总PSA测量可能难以区分是否患有癌症,目前应建议进行前列腺穿刺活检。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号